Kurs & Likviditet
Beskrivning
Land | Norge |
---|---|
Lista | OB Match |
Sektor | Hälsovård |
Industri | Bioteknik |
2021-10-21 08:00:00
Moss, 21 October 2021.
Gentian Diagnostics ASA, a fast-growing developer and manufacturer of diagnostic
tests, today announced its results for the third quarter of 2021.
Highlights:
Total operating revenue of NOK 19.4 million in Q3 2021, up 20% from Q3 2020.
EBITDA was NOK -4.2 million compared to NOK -5.5 in the corresponding quarter in
2020.
Sales revenue of NOK 17.2 million, a 30% growth compared to Q3 2020. Organic
growth in Q3 2021 was 37%.
Reached final stage of negotiations of a commercial collaboration contract with
a leading global diagnostics provider for GCAL®